Lumbab, Baby Boy .
HRN: 21-57-45 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/27/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/27/2022
09/03/2022
IV
18 Mg As LD Then 9mg
Q12H
Sepsis Neonatorum
Waiting Final Action
Indication: Empiric Type of Infection: Disseminated Systemic Infection Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes